Streetbeat News

Products Services

IREN

NVDA

Iris Energy has expanded its AI cloud services agreement with Poolside, increasing the contracted NVIDIA H100 GPUs from 248 to 504. The contract now extends for an additional 4 months starting mid-April 2024, with a possible 2-month extension.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:15 am

DNA

IdeeLab Biotechnology has entered into an agreement with Ginkgo Bioworks, allowing Ginkgo's customers access to IdeeLab's strain discovery and manufacturing facilities for next-generation products.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:13 am

AKTS

Akoustis Technologies, Inc. (AKTS) has secured a design win and volume orders for its Wi-Fi 7 solution with a Tier-1 enterprise class OEM. The OEM will use Akoustis' high-performance XBAW filters in a 4X4 MU-MIMO enterprise router platform, with volume orders supporting a production ramp in the second half of the calendar year 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:12 am

BRKR

Bruker Corporation (NASDAQ:BRKR), a leading provider of NMR spectroscopy solutions, has announced the introduction of novel high-resolution solid-state NMR scientific capabilities. These advancements are aimed at enabling unprecedented discoveries in structural biology, specifically in the study of large proteins, membrane proteins, and protein aggregates.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:11 am

LH

Labcorp announced the expansion of its precision oncology portfolio, including the launch of Labcorp Plasma Detect for molecular residual disease, enhancement of Labcorp Plasma Complete for ctDNA genomic profiling, and investment in cell and gene therapy capabilities.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:11 am

TECH

Bio-Techne Corporation announced that its division, Advanced Cell Diagnostics, has surpassed 10,000 peer-reviewed publications citing its RNAscope ISH technology. Over half of these publications were in the last 3 years, indicating growing global customer awareness and market adoption in spatial biology.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:11 am

SCNI

Scinai Immunotherapeutics' CDMO unit has entered into a five-year Master Service Agreement (MSA) with Ayana Pharma to provide drug development and cGMP manufacturing services. This includes aseptic filling, quality assurance, and encapsulating drug substances into Ayana's proprietary liposomal drug delivery system.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:10 am

AAPL

FXI

SPY

DigiTimes reported that an upcoming Huawei smartphone could potentially pressure iPhone sales in China, potentially affecting Apple's market share in the region.

Portfolio Pulse from Charles Gross

April 08, 2024 | 11:10 am

ALKS

Alkermes plc (NASDAQ:ALKS) presented long-term clinical data on LYBALVI for schizophrenia treatment at the SIRS 2024 Congress. The data comes from a phase 3 study showing LYBALVI's safety, tolerability, and effectiveness over four years. LYBALVI is approved in the U.S. for treating adults with schizophrenia and bipolar I disorder.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:10 am

PLUR

Pluri Inc. (NASDAQ:PLUR) announced a groundbreaking immune cell expansion technology and secured a new U.S. patent for it. This novel method, using proprietary 3D cell expansion technology, mimics the natural environment of immune cells, offering a promising solution for advanced cell-based therapies.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:07 am